Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

Nathan W.D. Lamond; Chris Skedgel; Daniel Rayson; Lynn Lethbridge; Tallal Younis

doi:10.1007/s10549-012-1989-5

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

Nathan W.D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Younis

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1115-1123
Number of pages	9
Journal	Breast Cancer Research and Treatment
Volume	133
Issue number	3
DOIs	https://doi.org/10.1007/s10549-012-1989-5
Publication status	Published - Jun 2012

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10549-012-1989-5

Cite this

Lamond, N. W. D., Skedgel, C., Rayson, D., Lethbridge, L., & Younis, T. (2012). Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer. Breast Cancer Research and Treatment, 133(3), 1115-1123. https://doi.org/10.1007/s10549-012-1989-5

@article{753fc6f4662c44c1acbd4a65b4d9b77d,

title = "Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer",

author = "Lamond, {Nathan W.D.} and Chris Skedgel and Daniel Rayson and Lynn Lethbridge and Tallal Younis",

note = "Funding Information: Acknowledgments This study has been supported by the Canadian Breast Cancer Foundation—Atlantic Chapter. The authors would like to thank Mrs. Marlene Sellon for her help with drug costing.",

year = "2012",

month = jun,

doi = "10.1007/s10549-012-1989-5",

language = "English",

volume = "133",

pages = "1115--1123",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

AU - Lamond, Nathan W.D.

AU - Skedgel, Chris

AU - Rayson, Daniel

AU - Lethbridge, Lynn

AU - Younis, Tallal

N1 - Funding Information: Acknowledgments This study has been supported by the Canadian Breast Cancer Foundation—Atlantic Chapter. The authors would like to thank Mrs. Marlene Sellon for her help with drug costing.

PY - 2012/6

Y1 - 2012/6

UR - http://www.scopus.com/inward/record.url?scp=84863723973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863723973&partnerID=8YFLogxK

U2 - 10.1007/s10549-012-1989-5

DO - 10.1007/s10549-012-1989-5

M3 - Article

C2 - 22361999

AN - SCOPUS:84863723973

SN - 0167-6806

VL - 133

SP - 1115

EP - 1123

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this